Industry Research Reports

Home > Reports > Service & Software > Global Lung Cancer Screening Software Market Research Report 2025

Global Lung Cancer Screening Software Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-20

Pages: 74 Pages

Report ld: 4017096

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Lung Cancer Screening Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lung Cancer Screening Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Lung Cancer Screening Software in Control and Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lung Cancer Screening Software include Nuance Communications Inc., Eon, Koninklijke Philips N.V., Siemens Healthineers AG, PenRad Technologies Inc., MRS Systems Inc., Magview, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Screening Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Screening Software.

The Lung Cancer Screening Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Screening Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Screening Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Nuance Communications Inc.
Eon
Koninklijke Philips N.V.
Siemens Healthineers AG
PenRad Technologies Inc.
MRS Systems Inc.
Magview

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cloud-Based
Web-Based

Segment by Application

Control and Monitoring
Data Management
Decision Support

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lung Cancer Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Screening Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cloud-Based

1.2.3 Web-Based

1.3 Market by Application

1.3.1 Global Lung Cancer Screening Software Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Control and Monitoring

1.3.3 Data Management

1.3.4 Decision Support

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Screening Software Market Perspective (2020-2031)

2.2 Global Lung Cancer Screening Software Growth Trends by Region

2.2.1 Global Lung Cancer Screening Software Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lung Cancer Screening Software Historic Market Size by Region (2020-2025)

2.2.3 Lung Cancer Screening Software Forecasted Market Size by Region (2026-2031)

2.3 Lung Cancer Screening Software Market Dynamics

2.3.1 Lung Cancer Screening Software Industry Trends

2.3.2 Lung Cancer Screening Software Market Drivers

2.3.3 Lung Cancer Screening Software Market Challenges

2.3.4 Lung Cancer Screening Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Screening Software Players by Revenue

3.1.1 Global Top Lung Cancer Screening Software Players by Revenue (2020-2025)

3.1.2 Global Lung Cancer Screening Software Revenue Market Share by Players (2020-2025)

3.2 Global Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lung Cancer Screening Software Revenue

3.4 Global Lung Cancer Screening Software Market Concentration Ratio

3.4.1 Global Lung Cancer Screening Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Screening Software Revenue in 2024

3.5 Global Key Players of Lung Cancer Screening Software Head office and Area Served

3.6 Global Key Players of Lung Cancer Screening Software, Product and Application

3.7 Global Key Players of Lung Cancer Screening Software, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Screening Software Breakdown Data by Type

4.1 Global Lung Cancer Screening Software Historic Market Size by Type (2020-2025)

4.2 Global Lung Cancer Screening Software Forecasted Market Size by Type (2026-2031)

5 Lung Cancer Screening Software Breakdown Data by Application

5.1 Global Lung Cancer Screening Software Historic Market Size by Application (2020-2025)

5.2 Global Lung Cancer Screening Software Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lung Cancer Screening Software Market Size (2020-2031)

6.2 North America Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lung Cancer Screening Software Market Size by Country (2020-2025)

6.4 North America Lung Cancer Screening Software Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Screening Software Market Size (2020-2031)

7.2 Europe Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lung Cancer Screening Software Market Size by Country (2020-2025)

7.4 Europe Lung Cancer Screening Software Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Screening Software Market Size (2020-2031)

8.2 Asia-Pacific Lung Cancer Screening Software Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2020-2025)

8.4 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Screening Software Market Size (2020-2031)

9.2 Latin America Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lung Cancer Screening Software Market Size by Country (2020-2025)

9.4 Latin America Lung Cancer Screening Software Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Screening Software Market Size (2020-2031)

10.2 Middle East & Africa Lung Cancer Screening Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2020-2025)

10.4 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nuance Communications Inc.

11.1.1 Nuance Communications Inc. Company Details

11.1.2 Nuance Communications Inc. Business Overview

11.1.3 Nuance Communications Inc. Lung Cancer Screening Software Introduction

11.1.4 Nuance Communications Inc. Revenue in Lung Cancer Screening Software Business (2020-2025)

11.1.5 Nuance Communications Inc. Recent Development

11.2 Eon

11.2.1 Eon Company Details

11.2.2 Eon Business Overview

11.2.3 Eon Lung Cancer Screening Software Introduction

11.2.4 Eon Revenue in Lung Cancer Screening Software Business (2020-2025)

11.2.5 Eon Recent Development

11.3 Koninklijke Philips N.V.

11.3.1 Koninklijke Philips N.V. Company Details

11.3.2 Koninklijke Philips N.V. Business Overview

11.3.3 Koninklijke Philips N.V. Lung Cancer Screening Software Introduction

11.3.4 Koninklijke Philips N.V. Revenue in Lung Cancer Screening Software Business (2020-2025)

11.3.5 Koninklijke Philips N.V. Recent Development

11.4 Siemens Healthineers AG

11.4.1 Siemens Healthineers AG Company Details

11.4.2 Siemens Healthineers AG Business Overview

11.4.3 Siemens Healthineers AG Lung Cancer Screening Software Introduction

11.4.4 Siemens Healthineers AG Revenue in Lung Cancer Screening Software Business (2020-2025)

11.4.5 Siemens Healthineers AG Recent Development

11.5 PenRad Technologies Inc.

11.5.1 PenRad Technologies Inc. Company Details

11.5.2 PenRad Technologies Inc. Business Overview

11.5.3 PenRad Technologies Inc. Lung Cancer Screening Software Introduction

11.5.4 PenRad Technologies Inc. Revenue in Lung Cancer Screening Software Business (2020-2025)

11.5.5 PenRad Technologies Inc. Recent Development

11.6 MRS Systems Inc.

11.6.1 MRS Systems Inc. Company Details

11.6.2 MRS Systems Inc. Business Overview

11.6.3 MRS Systems Inc. Lung Cancer Screening Software Introduction

11.6.4 MRS Systems Inc. Revenue in Lung Cancer Screening Software Business (2020-2025)

11.6.5 MRS Systems Inc. Recent Development

11.7 Magview

11.7.1 Magview Company Details

11.7.2 Magview Business Overview

11.7.3 Magview Lung Cancer Screening Software Introduction

11.7.4 Magview Revenue in Lung Cancer Screening Software Business (2020-2025)

11.7.5 Magview Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Lung Cancer Screening Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cloud-Based

Table 3. Key Players of Web-Based

Table 4. Global Lung Cancer Screening Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Lung Cancer Screening Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lung Cancer Screening Software Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Lung Cancer Screening Software Market Share by Region (2020-2025)

Table 8. Global Lung Cancer Screening Software Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Lung Cancer Screening Software Market Share by Region (2026-2031)

Table 10. Lung Cancer Screening Software Market Trends

Table 11. Lung Cancer Screening Software Market Drivers

Table 12. Lung Cancer Screening Software Market Challenges

Table 13. Lung Cancer Screening Software Market Restraints

Table 14. Global Lung Cancer Screening Software Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Lung Cancer Screening Software Market Share by Players (2020-2025)

Table 16. Global Top Lung Cancer Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2024)

Table 17. Ranking of Global Top Lung Cancer Screening Software Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Lung Cancer Screening Software Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Lung Cancer Screening Software, Headquarters and Area Served

Table 20. Global Key Players of Lung Cancer Screening Software, Product and Application

Table 21. Global Key Players of Lung Cancer Screening Software, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Lung Cancer Screening Software Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Lung Cancer Screening Software Revenue Market Share by Type (2020-2025)

Table 25. Global Lung Cancer Screening Software Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Lung Cancer Screening Software Revenue Market Share by Type (2026-2031)

Table 27. Global Lung Cancer Screening Software Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Lung Cancer Screening Software Revenue Market Share by Application (2020-2025)

Table 29. Global Lung Cancer Screening Software Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Lung Cancer Screening Software Revenue Market Share by Application (2026-2031)

Table 31. North America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Lung Cancer Screening Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Lung Cancer Screening Software Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Screening Software Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Lung Cancer Screening Software Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Screening Software Market Size by Country (2026-2031) & (US$ Million)

Table 46. Nuance Communications Inc. Company Details

Table 47. Nuance Communications Inc. Business Overview

Table 48. Nuance Communications Inc. Lung Cancer Screening Software Product

Table 49. Nuance Communications Inc. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 50. Nuance Communications Inc. Recent Development

Table 51. Eon Company Details

Table 52. Eon Business Overview

Table 53. Eon Lung Cancer Screening Software Product

Table 54. Eon Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 55. Eon Recent Development

Table 56. Koninklijke Philips N.V. Company Details

Table 57. Koninklijke Philips N.V. Business Overview

Table 58. Koninklijke Philips N.V. Lung Cancer Screening Software Product

Table 59. Koninklijke Philips N.V. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 60. Koninklijke Philips N.V. Recent Development

Table 61. Siemens Healthineers AG Company Details

Table 62. Siemens Healthineers AG Business Overview

Table 63. Siemens Healthineers AG Lung Cancer Screening Software Product

Table 64. Siemens Healthineers AG Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 65. Siemens Healthineers AG Recent Development

Table 66. PenRad Technologies Inc. Company Details

Table 67. PenRad Technologies Inc. Business Overview

Table 68. PenRad Technologies Inc. Lung Cancer Screening Software Product

Table 69. PenRad Technologies Inc. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 70. PenRad Technologies Inc. Recent Development

Table 71. MRS Systems Inc. Company Details

Table 72. MRS Systems Inc. Business Overview

Table 73. MRS Systems Inc. Lung Cancer Screening Software Product

Table 74. MRS Systems Inc. Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 75. MRS Systems Inc. Recent Development

Table 76. Magview Company Details

Table 77. Magview Business Overview

Table 78. Magview Lung Cancer Screening Software Product

Table 79. Magview Revenue in Lung Cancer Screening Software Business (2020-2025) & (US$ Million)

Table 80. Magview Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. Lung Cancer Screening Software Picture

Figure 2. Global Lung Cancer Screening Software Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lung Cancer Screening Software Market Share by Type: 2024 VS 2031

Figure 4. Cloud-Based Features

Figure 5. Web-Based Features

Figure 6. Global Lung Cancer Screening Software Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Lung Cancer Screening Software Market Share by Application: 2024 VS 2031

Figure 8. Control and Monitoring Case Studies

Figure 9. Data Management Case Studies

Figure 10. Decision Support Case Studies

Figure 11. Lung Cancer Screening Software Report Years Considered

Figure 12. Global Lung Cancer Screening Software Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lung Cancer Screening Software Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lung Cancer Screening Software Market Share by Region: 2024 VS 2031

Figure 15. Global Lung Cancer Screening Software Market Share by Players in 2024

Figure 16. Global Top Lung Cancer Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Screening Software Revenue in 2024

Figure 18. North America Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lung Cancer Screening Software Market Share by Country (2020-2031)

Figure 20. United States Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lung Cancer Screening Software Market Share by Country (2020-2031)

Figure 24. Germany Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lung Cancer Screening Software Market Share by Region (2020-2031)

Figure 32. China Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lung Cancer Screening Software Market Share by Country (2020-2031)

Figure 40. Mexico Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lung Cancer Screening Software Market Share by Country (2020-2031)

Figure 44. Turkey Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Lung Cancer Screening Software Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Nuance Communications Inc. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 48. Eon Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 49. Koninklijke Philips N.V. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 50. Siemens Healthineers AG Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 51. PenRad Technologies Inc. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 52. MRS Systems Inc. Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 53. Magview Revenue Growth Rate in Lung Cancer Screening Software Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Lung Cancer Screening Software market? zhanKai

The top companies in the global Lung Cancer Screening Software market are Nuance Communications Inc.、Eon、Koninklijke Philips N.V..

Related Reports

Global Lung Cancer Screening Software Market Research Report 2026
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 115
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-14
Pages: 132
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 117
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published Date: 2026-01-14
Pages: 98
USD 4250.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 126
USD 4900.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 77
USD 4250.00
(Single User License)
Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 100
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 92
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 79
USD 2900.00
(Single User License)

Global Lung Cancer Screening Software Market Research Report 2026
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 115
USD 2900.00 (Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-14
Pages: 132
USD 4900.00 (Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 117
USD 3950.00 (Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published: 2026-01-14
Pages: 98
USD 4250.00 (Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 126
USD 4900.00 (Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 77
USD 4250.00 (Single User License)
Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 100
USD 3950.00 (Single User License)
Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 92
USD 3950.00 (Single User License)
Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 79
USD 2900.00 (Single User License)